Fortunes of Indian pharmacos may get Trumped

US tariffs on Indian drugs may raise costs, cause shortages The United States’ plan to impose a 25% tariff on Indian pharmaceutical imports is poised to have significant repercussions for both the U.S. healthcare system and India’s pharmaceutical industry. India supplies nearly half of all generic drugs consumed in the U.S., leading to substantial savings—estimated…